Technology
Health
Biotechnology

NextCure

1,194

$35.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.38 (+4.09%) As of 11:23 AM EDT today
+$1.38 (+4.09%) Today

Why Robinhood?

You can buy or sell NextCure and other stocks, options, ETFs, and crypto commission-free!

About NXTC

NextCure, Inc. Common Stock, also called NextCure, is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Read More Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.

CEO
Michael S. Richman
Employees
69
Headquarters
Beltsville, Maryland
Founded
2015
Market Cap
1.03B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
222.40K
High Today
$35.57
Low Today
$33.76
Open Price
$34.14
Volume
45.48K
52 Week High
$109.00
52 Week Low
$13.86

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Cancer Prevention
Pharmaceutical
2019 IPO

NXTC Earnings

-$4.46
-$2.97
-$1.49
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Sep 12, Pre-Market

People Also Bought

Luckin Coffee

104,058

$4.39

0.00%

Luckin Coffee

104,058

$4.39

0.00%

Virgin Galactic Holdings

94,950

$15.07

+7.11%

Viking Therapeutics

53,030

$4.72

+3.28%

NIO

127,505

$2.75

+1.85%

You May Also Like

KMED
PXE
EOI
HPI
TRC
FHI
BNY
NURE
AFIN
USAP
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy NXTC

Market Price$35.13
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell NextCure stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up